Dravet syndrome as epileptic encephalopathy: evidence from long-term course and neuropathology
Open accessThe DOI matches its Crossref record; 87 of the 88 references it cites were found in a registry or an index.
Abstract
Dravet syndrome is an epilepsy syndrome of infantile onset, frequently caused by SCN1A mutations or deletions. Its prevalence, long-term evolution in adults and neuropathology are not well known. We identified a series of 22 adult patients, including three adult post-mortem cases with Dravet syndrome. For all patients, we reviewed the clinical history, seizure types and frequency, antiepileptic drugs, cognitive, social and functional outcome and results of investigations. A systematic neuropathology study was performed, with post-mortem material from three adult cases with Dravet syndrome, in comparison with controls and a range of relevant paediatric tissue. Twenty-two adults with Dravet syndrome, 10 female, were included, median age 39 years (range 20-66). SCN1A structural variation was found in 60% of the adult Dravet patients tested, including one post-mortem case with DNA extracted from brain tissue. Novel mutations were described for 11 adult patients; one patient had three SCN1A mutations. Features of Dravet syndrome in adulthood include multiple seizure types despite polytherapy, and age-dependent evolution in seizure semiology and electroencephalographic pattern. Fever sensitivity persisted through adulthood in 11 cases. Neurological decline occurred in adulthood with cognitive and motor deterioration. Dysphagia may develop in or after the fourth decade of life, leading to significant morbidity, or death. The correct diagnosis at an older age made an impact at several levels. Treatment changes improved seizure control even after years of drug resistance in all three cases with sufficient follow-up after drug changes were instituted; better control led to significant improvement in cognitive performance and quality of life in adulthood in two cases. There was no histopathological hallmark feature of Dravet syndrome in this series. Strikingly, there was remarkable preservation of neurons and interneurons in the neocortex and hippocampi of Dravet adult post-mortem cases. Our study provides evidence that Dravet syndrome is at least in part an epileptic encephalopathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures











Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For example, cessation of specific sodium channel blockers, which are contraindicated in Dravet syndrome, leads to improved seizure control and developmental gains in children and adults with Dravet syndrome 232 .”
From Developmental and epileptic encephalopathies (2024) · cites this paper as [232]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Berg, A. T., Berkovic, S. F., Brodie, M. J., Buchhalter, J., Cross, J. H., Van Emde Boas, W., Engel, J., French, J., Glauser, T. A., Mathern, G. W., et al. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2010.02522.x · Cited by 4,363 · cited 2×
“…Against Epilepsy classification (Engel et al., 2001) and a syndrome carrying higher risk of epileptic encephalopathy in the recent reorganization (Berg et al., 2010), but controversy exists as to whether the seizures and interictal discharges themselves are responsible for the cognitive…”
BackgroundSelf-citationEngel, J. (2001) · Epilepsia · doi:10.1046/j.1528-1157.2001.10401.x · Cited by 2,251
Blümcke, I., Thom, M., Aronica, E., Armstrong, D. D., Vinters, H. V., Palmini, A., Jacques, T. S., Avanzini, G., Barkovich, A. J., Battaglia, G., et al. (2011) · Epilepsia · doi:10.1111/j.1528-1167.2010.02777.x · Cited by 1,743
Self-citationDe Novo Mutations in the Sodium-Channel Gene SCN1A Cause Severe Myoclonic Epilepsy of Infancy
Claes, L., Del-Favero, J., Ceulemans, B., Lagae, L., Van Broeckhoven, C., & De Jonghe, P. (2001) · The American Journal of Human Genetics · doi:10.1086/320609 · Cited by 1,292
Yu, F. H., Mantegazza, M., Westenbroek, R. E., Robbins, C. A., Kalume, F., Burton, K. A., Spain, W. J., McKnight, G. S., Scheuer, T., & Catterall, W. A. (2006) · Nature Neuroscience · doi:10.1038/nn1754 · Cited by 1,173 · cited 7×
“1) in Purkinje cells, leading to abnormal sodium flux, may contribute to ataxia observed in animal models (Yu et al., 2006).”
BackgroundResultInfluentialBrain Inflammation in Epilepsy: Experimental and Clinical Evidence
Vezzani, A., & Granata, T. (2005) · Epilepsia · doi:10.1111/j.1528-1167.2005.00298.x · Cited by 1,036 · cited 1×
“Immune-inflammatory mediators have received attention in epileptogenesis, febrile seizures and some chronic epilepsies (Vezzani and Granata, 2005; Ravizza et al., 2008; Vezzani et al., 2008).”
Background(2005) · Cited by 944
Ogiwara, I., Miyamoto, H., Morita, N., Atapour, N., Mazaki, E., Inoue, I., Takeuchi, T., Itohara, S., Yanagawa, Y., Obata, K., et al. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.5270-06.2007 · Cited by 879 · cited 4×
“Sodium currents are significantly reduced in inhibitory interneurons in both hippocampus and cortex, but less so in hippocampal pyramidal cells (Yu et al., 2006; Ogiwara et al., 2007).”
BackgroundResultInfluentialRavizza, T., Gagliardi, B., Noé, F., Boer, K., Aronica, E., & Vezzani, A. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.08.012 · Cited by 699 · cited 1×
“Immune-inflammatory mediators have received attention in epileptogenesis, febrile seizures and some chronic epilepsies (Vezzani and Granata, 2005; Ravizza et al., 2008; Vezzani et al., 2008).”
Background
Research works printed but not linked: 3
- 2009, Journal of Medical Genetics, 46, 183, 10.1136/jmg.2008.062323 · DOI · Paper page
- 2009, Journal of Medical Genetics, 46, 671, 10.1136/jmg.2008.060897 · DOI · Paper page
- 2010, Journal of Biological Chemistry, 285, 9823, 10.1074/jbc.m109.078568 · DOI · Paper page
Cited by
Items 101–200 of 232
Cognitive characterization of children with Dravet syndrome: A neurodevelopmental perspective
Acha, J., Pérez, A., Davidson, D. J., & Carreiras, M. (2014) · Child Neuropsychology · doi:10.1080/09297049.2014.959480 · Cited by 23
“Overall, these findings shed some light onto the possible key roles of seizure onset and frequency in cognitive decline and phenotype variability also in DS (Catarino et al., 2011), although there is still a debate about the impact of other factors such as medical treatment (see Loring & Meador, 2004; but also Wolff e…”
InfluentialIctal ontogeny in Dravet syndrome
Kim, S. H., Nordli, D. R., Berg, A. T., Koh, S., & Laux, L. (2014) · Clinical Neurophysiology · doi:10.1016/j.clinph.2014.06.024 · Cited by 21
Jaber, D., Gitiaux, C., Blesson, S., Marguet, F., Buard, D., Salgado, M. V., Kamińska, A., Saada, J., Fallet‐Bianco, C., Martinovic, J., et al. (2020) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2020-107166 · Cited by 21
Genetic investigation for adults with intellectual disability: opportunities and challenges
Baker, K., Raymond, F. L., & Bass, N. J. (2012) · Current Opinion in Neurology · doi:10.1097/wco.0b013e328351820e · Cited by 25
Cagigal, R., del Rincón, C. R., Fernández‐Perrone, A. L., Cruz, R., Møller, R. S., & Aledo‐Serrano, Á. (2025) · Epilepsia · doi:10.1111/epi.18426 · Cited by 21
“In adults with DS, neuropathological findings indicate that neuronal structures remain largely preserved despite chronic seizures, 17 but there may be functional alterations at the network level due to secondary epileptogenesis over time.”
Carbamazepine and oxcarbazepine in adult patients with Dravet syndrome: Friend or foe?
Snoeijen‐Schouwenaars, F. M., Veendrick, M. J. B. M., van Mierlo, P., van Erp, G., de Louw, A. J. A., Kleine, B. U., Schelhaas, H. J., & Tan, F. I. Y. (2015) · Seizure · doi:10.1016/j.seizure.2015.03.010 · Cited by 21
“Furthermore, in mouse models, the antiepileptic efficacy of stiripentol diminishes with age [2] and combinations of drugs may be synergistic for one seizure type, but not for another [13].”
BackgroundLate diagnoses of Dravet syndrome: How many individuals are we missing?
Silvennoinen, K., Puvirajasinghe, C., Hudgell, K., Sidhu, M. K., Custodio, H. M., Jones, W. D., Balestrini, S., & Sisodiya, S. M. (2021) · Epilepsia Open · doi:10.1002/epi4.12525 · Cited by 22
Self-citationFatal Status Epilepticus in Dravet Syndrome
Liso, P. D., Pironi, V., Mastrangelo, M., Battaglia, D., Craiu, D., Trivisano, M., Specchio, N., Nabbout, R., & Vigevano, F. (2020) · Brain Sciences · doi:10.3390/brainsci10110889 · Cited by 20
Does long‐term phenytoin have a place in Dravet syndrome?
Zographos, G. A., Russ‐Hall, S. J., & Scheffer, I. E. (2022) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51684 · Cited by 17
“reports mixed responses to phenytoin in the three of 22 patients who received phenytoin.(13) One had seizure exacerbation, one had seizure improvement, and one had improved control of GTCS and exacerbation of myoclonic seizures.”
BackgroundSelf-citationTwo autopsy cases of sudden unexpected death from Dravet syndrome with novel de novo SCN1A variants
Hata, Y., Oku, Y., Taneichi, H., Tanaka, T., Igarashi, N., Niida, Y., & Nishida, N. (2019) · Brain and Development · doi:10.1016/j.braindev.2019.10.005 · Cited by 17
Brain morphometry of Dravet Syndrome
Pérez, A., García‐Pentón, L., Canales-Rodríguez, E. J., Lerma‐Usabiaga, G., Iturria‐Medina, Y., Román, F. J., Davidson, D. J., Alemán‐Gómez, Y., Acha, J., & Carreiras, M. (2014) · Epilepsy Research · doi:10.1016/j.eplepsyres.2014.06.006 · Cited by 18
Pharmacology aspects during transition and at transfer in patients with epilepsy
Chiron, C., & Gourfinkel‐An, I. (2014) · Epilepsia · doi:10.1111/epi.12708 · Cited by 17
“In one Dravet syndrome cohort (n = 22, age range 20–66 years), stopping AEDs that exacerbate epilepsy (six cases) and starting new AED options (n = 7) improved seizure control in all cases (7/7) and improved cognitive performances in two of the three cases during follow-up.(13) Therefore, optimizing AED treatment at a…”
BackgroundRubio, M., Valdeolivas, S., Piscitelli, F., Verde, R., Satta, V., Barroso, E., Montolio, M., Aras, L. M., Marzo, V. D., Sagredo, O., et al. (2016) · Pharmacology Research & Perspectives · doi:10.1002/prp2.220 · Cited by 20
Stiripentol and vigabatrin current roles in the treatment of epilepsy
Chiron, C. (2016) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2016.1161026 · Cited by 20
“[26,42,43] Since epilepsy is known to persist in adulthood in Dravet patients [44] and preliminary data suggest that STP efficacy”
BackgroundEarly-onset genetic epilepsies reaching adult clinics
Lewis‐Smith, D., Ellis, C. A., Helbig, I., & Thomas, R. H. (2020) · Brain · doi:10.1093/brain/awaa029 · Cited by 17
“The majority of adults with early-onset epilepsies, however, will not have benefited from recent genetic diagnostic discoveries (Catarino et al., 2011).”
BackgroundDo Seizures Damage the Brain ?—Cumulative Effects of Seizures and Epilepsy: A 2025 Perspective
Klein, P., Carrazana, E. J., Glauser, T. A., Herman, B. P., Penovich, P. E., Rabinowicz, A. L., & Sutula, T. P. (2025) · Epiliepsy currents/Epilepsy currents · doi:10.1177/15357597251331927 · Cited by 18
“Not all pathological studies have detected neuronal loss in patients with intractable epilepsy and status epilepticus, 45,46 but the largest study to date of resected pathology of surgically treated, medically intractable patients with TLE and frontal lobe epilepsy (FLE) reported different patterns…”
Huang, H., & Shakkottai, V. G. (2023) · Life · doi:10.3390/life13061350 · Cited by 16
“1 Dravet syndrome Cerebellar atrophy on MRI; Cerebellar atrophy with loss of Purkinje neuron on post-mortem tissue [30].”
BackgroundElder, C. J., Kerestes, R., Opal, P., Marchese, M., & Devinsky, O. (2025) · Epilepsia · doi:10.1111/epi.18316 · Cited by 16
Sudden death in epilepsy: There is room for intracranial pressure
Dibué, M., Spoor, J. K. H., Dremmen, M. H. G., von Saß, C. F., Hänggi, D., Steiger, H., Ryvlin, P., & Kamp, M. A. (2020) · Brain and Behavior · doi:10.1002/brb3.1838 · Cited by 16
Adult Phenotype of SYNGAP1 -DEE
Rong, M., Benke, T. A., Ali, Q. Z., Aledo‐Serrano, Á., Bayat, A., Rossi, A., Devinsky, O., Qaiser, F., Ali, A., Fasano, A. A., et al. (2023) · Neurology Genetics · doi:10.1212/nxg.0000000000200105 · Cited by 15
“32,33 Although direct comparisons cannot be made, it is possible that this may be the case in some adults with SYNGAP1 .”
BackgroundThe concept of disease modification
Cross, J. H., & Lagae, L. G. (2019) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2019.12.005 · Cited by 15
Self-citationPerampanel Reduces Hyperthermia-Induced Seizures in Dravet Syndrome Mouse Model
Ho, S., Lin, L., Chen, I., Tsai, C., Chang, F., & Liou, H. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.682767 · Cited by 15
Haginoya, K., Togashi, N., Kaneta, T., Hino‐Fukuyo, N., Ishitobi, M., Kakisaka, Y., Uematsu, M., Inui, T., Okubo, Y., Sato, R., et al. (2018) · Epilepsy Research · doi:10.1016/j.eplepsyres.2018.08.008 · Cited by 15
Sleep disturbances and health-related quality of life in children with epilepsy: A caregiver survey
Wiesmüller, L., Strauch, D., Schönberger, J., Antonio‐Arce, V. S., Bast, T., Schubert‐Bast, S., Syrbe, S., Jacobs, J., & Klotz, K. A. (2025) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2025.110613 · Cited by 14
Balestrini, S., Guerrini, R., & Sisodiya, S. M. (2021) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-021-01154-7 · Cited by 14
Self-citationTemporal manipulation of the Scn1a gene reveals its essential role in adult brain function
Berardino, C. D., Mainardi, M., Brusco, S., Benvenuto, E., Broccoli, V., & Colasante, G. (2023) · Brain · doi:10.1093/brain/awad350 · Cited by 14
“42,43 44-46 The results of this study also have implications for precision medicine approaches that are being developed for this syndrome.”
BackgroundCha, J., Filatov, G., Smith, S. J., Gammaitoni, A. R., Lothe, A., & Reeder, T. (2023) · Epilepsia Open · doi:10.1002/epi4.12873 · Cited by 14
“29 It is unclear whether myelination protection/repair is a secondary consequence of reduced seizure activity by fenfluramine, whether fenfluramine acts through a direct mechanism that either protects or repairs myelin, or a combination of both.”
BackgroundSelf-citationElectroencephalogram of Age-Dependent Epileptic Encephalopathies in Infancy and Early Childhood
Wong‐Kisiel, L. C., & Nickels, K. C. (2013) · Epilepsy Research and Treatment · doi:10.1155/2013/743203 · Cited by 17
SCN2A and Its Related Epileptic Phenotypes
Praticò, A. D., Giallongo, A., Arrabito, M., D'Amico, S., Gauci, M. C., Lombardo, G., Polizzi, A., Falsaperla, R., & Ruggieri, M. (2021) · Journal of Pediatric Neurology · doi:10.1055/s-0041-1727097 · Cited by 13
SCN1A Gene Mutation and Adaptive Functioning in 18 Vietnamese Children with Dravet Syndrome
Do, H., Vu, D. M., Huynh, T. T. K., Le, T. K. V., Sohn, E.-H., Le, T. M. T., Ha, H. H., & Bui, C. (2017) · Journal of Clinical Neurology · doi:10.3988/jcn.2017.13.1.62 · Cited by 13
Exploration of the mechanism of action of cenobamate
Sankar, R., Ferrari, L., & Kamin, M. (2025) · Seizure · doi:10.1016/j.seizure.2025.11.010 · Cited by 12
Feeding Difficulties and Gastrostomy in Dravet Syndrome: A UK-Wide Survey and 2-Center Experience
Clayton, L. M. S., Azadi, B., Eldred, C., Wilson, G., Robinson, R. A., & Sisodiya, S. M. (2024) · Neurology Clinical Practice · doi:10.1212/cpj.0000000000200288 · Cited by 11
Self-citationPizzamiglio, L., Capitano, F., Rusina, E., Fossati, G., Menna, E., Léna, I., Antonucci, F., & Mantegazza, M. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.106853 · Cited by 10
Stenhouse, S., Ellis, R., & Zuberi, S. M. (2013) · PLoS Currents · doi:10.1371/currents.eogt.c553b83d745dd79bfb61eaf35e522b0b · Cited by 10
Self-citationTransition to adult life in the monogenic epilepsies
Scheffer, I. E., & Dravet, C. (2014) · Epilepsia · doi:10.1111/epi.12707 · Cited by 12
Self-citationAdaptive behaviour in adolescents and adults with Dravet syndrome
Barco, T. L., Offredi, F., Castino, E., Proietti, J., Cossu, A., Fiorini, E., Fontana, E., Cantalupo, G., Bernardina, B. D., & Darra, F. (2022) · Developmental Medicine & Child Neurology · doi:10.1111/dmcn.15448 · Cited by 10
Morphometry and network-based atrophy patterns in SCN1A -related Dravet syndrome
Lenge, M., Balestrini, S., Mei, D., Macconi, L., Caligiuri, M. E., Cuccarini, V., Aquino, D., Mazzi, F., D’Incerti, L., Darra, F., et al. (2023) · Cerebral Cortex · doi:10.1093/cercor/bhad224 · Cited by 10
“Our hypothesis is that the underlying neurophysiological dysfunction caused by the SCN1A mutation might confer to the brain a unique profile of vulnerability whose consequences are not easily disclosed by classical neuropathology (Catarino et al. 2011; Guerrini et al. 2011).”
BackgroundEpileptic Encephalopathies in Adults and Childhood
Kural, Z., & Özer, A. F. (2012) · Epilepsy Research and Treatment · doi:10.1155/2012/205131 · Cited by 10
Richards, K., Jancovski, N., Hanssen, E. G., Connelly, A., & Petrou, S. (2020) · Brain Research · doi:10.1016/j.brainres.2020.147157 · Cited by 10
The social and emotional burden of Dravet syndrome on Spanish caregivers
Marco, N. S., Giorgi, S., & Aibar, J. Á. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e34771 · Cited by 9
“Only 24.11 % of persons with DS (27/112) were of legal age and around half of their caregivers (51.85 %, [14/27]) were granted the legal extension of parental rights (Fig.”
BackgroundInfluentialSomatosensory reflex seizures in a child with epilepsy related to novel SCN1A mutation
Arıcan, P., Dündar, N. O., Çavuşoğlu, D., Özdemir, T. R., & Gençpınar, P. (2016) · Child s Nervous System · doi:10.1007/s00381-016-3297-6 · Cited by 9
Riza, A., Streață, I., Roza, E., Budișteanu, M., Iliescu, C., Burloiu, C., Dobrescu, M. A., Dorobantu, S., Dragos, A., Grigorescu, A., et al. (2022) · Genes · doi:10.3390/genes13071253 · Cited by 9
Kürekçi, F., Kılıç, M. A., Akbaş, S., Avci, R., Oney, C., Aslanger, A. D., Genç, H. M., Aydınli, N., & Yıldız, E. P. (2024) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2024.109930 · Cited by 8
Adult phenotypes of genetic developmental and epileptic encephalopathies
Vakrinou, A., Pagni, S., Mills, J. D., Clayton, L. M. S., Balestrini, S., & Sisodiya, S. M. (2024) · Brain Communications · doi:10.1093/braincomms/fcaf028 · Cited by 9
“7 The majority of adults alive today with a genetic DEE will not have benefited from recent diagnostic and treatment discoveries, 27 such that data on the long-term course could be considered to approximate natural history outcomes, as data are drawn from individuals not intentionally treated with…”
Self-citationInfluence of stiripentol on perampanel serum levels
Trabs, N., Trabs, M., Stodieck, S. R. G., & House, P. M. (2020) · Epilepsy Research · doi:10.1016/j.eplepsyres.2020.106367 · Cited by 8
Monogenic Epilepsies in Adult Epilepsy Clinics and Gene-Driven Approaches to Treatment
Clayton, L. M. S., Vakrinou, A., Balestrini, S., & Sisodiya, S. M. (2025) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-025-01413-x · Cited by 8
“The majority of adults alive today with a DEE, other early-onset epilepsy, or neurodevel-opmental disorder with epilepsy will not have benefited from recent genetic diagnostic discoveries, and, in adults with compatible phenotypes, genetic testing should be considered (see below) [22–24].”
Self-citationLong‐lasting remodeling of astrocytes in an Scna1 +/− mouse model of Dravet syndrome
Génin, A., Janvier, A., Moujellil-Legagneur, T., Blaquière, M., Chaussy, A., Privé, R., Duprat, F., Mantegazza, M., Audinat, É., Marchi, N., et al. (2026) · Epilepsia · doi:10.1002/epi.70185 · Cited by 8
“12,13 In some forms of epilepsy, such as temporal lobe and focal cortical seizures, astrocytes undergo a reactive transformation, which disrupts their homeostatic functions.”
Case report: Dravet syndrome, feeding difficulties and gastrostomy
Clayton, L. M. S., Williams, E., Balestrini, S., & Sisodiya, S. M. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.993906 · Cited by 8
“Reducing seizure burden in DS has beneficial effects beyond seizure control, including improvements in cognition, language and mobility (35), but there is insufficient evidence to suggest that treatment with antiseizure medications have a direct influence on other wider disease manifestations, such as neurodevelopment…”
BackgroundSelf-citationVeltra, D., Theodorou, V., Katsalouli, M., Vorgia, P., Niotakis, G., Tsaprouni, T., Pons, R. M., Kosma, K., Kampouraki, A., Tsoutsou, I., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25115644 · Cited by 7
“SCN1A:p.I1523L is also a novel variant however a different substitution affecting the same amino acid, p.(I523T), has been recorded in a female patient with FS onset at 6 years of age, inducing developmental delay, and evolving to tonic–clonic and SE in adulthood [28].”
BackgroundMcTague, A., Scheffer, I. E., Kullmann, D. M., & Sisodiya, S. M. (2024) · Handbook of clinical neurology · doi:10.1016/b978-0-323-90820-7.00016-1 · Cited by 8
Self-citationZhou, C., Satpute, V., Yip, K. L., Anderson, L. L., Hawkins, N. A., Kearney, J. A., & Arnold, J. C. (2024) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2024.106836 · Cited by 6
Gene therapy for Dravet syndrome: promises and impact on disease trigger and secondary modifications
Berardino, C. D., Massimino, L., Ungaro, F., & Colasante, G. (2024) · Rare Disease and Orphan Drugs Journal · doi:10.20517/rdodj.2024.07 · Cited by 6
Variants in ATP6V0C are associated with Dravet‐like developmental and epileptic encephalopathy
Rong, M., Marques, P., Ali, Q. Z., Morcos, R., Chandran, I., Qaiser, F., Møller, R. S., Bayat, A., Rubboli, G., Gardella, E., et al. (2025) · Epilepsia · doi:10.1111/epi.18346 · Cited by 6
Self-citationCardenal‐Muñoz, E., Nabbout, R., Boronat, S., Herguedas, J. L., Villanueva, V., & Aibar, J. Á. (2021) · Revista de Neurología · doi:10.33588/rn.7302.2021006 · Cited by 6
Neuropathology findings in KCNQ2 neonatal epileptic encephalopathy.
Legros, L., Adle‐Biassette, H., Dozières‐Puyravel, B., Khung‐Savatovsky, S., Elmaleh, M., Lesca, G., Delanöe, C., Biran, V., & Auvin, S. (2022) · Seizure · doi:10.1016/j.seizure.2022.05.008 · Cited by 7
Children as voices and images for medicinal cannabis law reform
Qc, I. F. A. (2021) · Monash Bioethics Review · doi:10.1007/s40592-021-00139-z · Cited by 6
Terminology and prognosis of D ravet syndrome
Dravet, C. (2014) · Epilepsia · doi:10.1111/epi.12626 · Cited by 6
The role of epigenetics in the pathophysiology of epilepsy
Nam, S. M., & Cho, K. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800226-1.00012-5 · Cited by 7
Developmental and epileptic encephalopathies
Gill, R. E., Ludwig, N. N., & Stafstrom, C. E. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-824060-1.00009-2 · Cited by 5
Alowaysi, M., Al-Shehri, M., Badkok, A., Attas, H., Aboalola, D. A., Baadhaim, M., Alzahrani, H., Daghestani, M., Zia, A., Al-Ghamdi, K., et al. (2023) · Human Cell · doi:10.1007/s13577-023-01016-z · Cited by 5
“DRVT clinical manifestations include seizures, developmental delay, ataxia, and cognitive impairment, suggesting pathophysiological processes that impair brain development [4–6].”
BackgroundNovel neuropathological observations in an adult with Dravet syndrome
Andrade, D. M., Bassett, A. S., Ali, Q. Z., Lira, V., Reyes, N. G. D., Tartaglia, M. C., Fasano, A. A., & Kovács, G. G. (2025) · Epilepsia · doi:10.1111/epi.18613 · Cited by 4
Sierra‐Marcos, A., Nogué, R. R., Vidal‐Robau, N., Aldecoa, I., Turón‐Viñas, E., Rodríguez‐Santiago, B., Turón, M., Boronat, S., & Molina‐Porcel, L. (2023) · Epilepsy Research · doi:10.1016/j.eplepsyres.2023.107266 · Cited by 4
A novel SCN1A mutation: A case report
Aslan, M., Özgör, B., Kırık, S., & Güngör, S. (2020) · Journal of Pediatric Neurosciences · doi:10.4103/jpn.jpn_118_18 · Cited by 4
Disease Modification in Epilepsy: Behavioural Accompaniments
Russo, E., & Citraro, R. (2021) · Current topics in behavioral neurosciences · doi:10.1007/7854_2020_216 · Cited by 4
Hernández, A. V. M., Caro‐Llopis, A., Rubio-Sanchez, P., Martínez, J. C., Vila, M. T., Monfort, S., & Martínez, F. (2022) · Journal of Child Neurology · doi:10.1177/08830738211072694 · Cited by 4
The role of epigenetics in the pathophysiology of epilepsy
Cho, K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-18516-8.00006-5 · Cited by 4
Scheffer, I. E., Perucca, P., & Karoly, P. J. (2025) · Annals of Neurology · doi:10.1002/ana.78111 · Cited by 3
“14 This observation highlights that ameliorating the epileptic encephalopathy component of their disease can improve daily function even at older ages, and that adults deserve consideration for novel therapies.”
Self-citationA case of Dravet syndrome with a novel SCN1A gross deletion involving the promoter region
Sakamoto, E. N., Shimada, S., Yamaguchi, T., Ishida, T., Imai, K., Eguchi, H., Okazaki, Y., & Arai, M. (2025) · Human Genome Variation · doi:10.1038/s41439-025-00320-4 · Cited by 3
Dramatic seizure reduction with levetiracetam in adult Dravet syndrome: a case report
Inoue, S., Yazawa, S., Murahara, T., Yamauchi, R., & Shimohama, S. (2015) · Rinsho Shinkeigaku · doi:10.5692/clinicalneurol.55.151 · Cited by 3
Complex epilepsy: it’s all in the history
Silvennoinen, K., Custodio, H. M., Balestrini, S., Rugg‐Gunn, F. J., & Sisodiya, S. M. (2020) · Practical Neurology · doi:10.1136/practneurol-2020-002522 · Cited by 3
Self-citationSolving the Molecular Basis of the Developmental and Epileptic Encephalopathies: Are We there Yet?
Scheffer, I. E. (2021) · Epiliepsy currents/Epilepsy currents · doi:10.1177/15357597211038180 · Cited by 3
Self-citationRosch, R. E., & Goldberg, E. M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-89932-1.00015-9 · Cited by 4
Inoue, T., Kawawaki, H., Kuki, I., Nabatame, S., Tomonoh, Y., Sukigara, S., Horino, A., Nukui, M., Okazaki, S., Tomiwa, K., et al. (2013) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2013.01.038 · Cited by 3
Mahdieh, N., Mikaeeli, S., Badv, R. S., Shirazi, A. G., Maleki, M., & Rabbani, B. (2018) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2018.01.030 · Cited by 3
Gibt es operative Behandlungsoptionen bei genetischen fokalen Epilepsien?
Antonio‐Arce, V. S. (2019) · Clinical Epileptology · doi:10.1007/s10309-019-0268-4 · Cited by 3
Higurashi, N., Okano, H., & Hirose, S. (2013) · Future Neurology · doi:10.2217/fnl.13.34 · Cited by 3
Fever-induced seizures: where are we today?
Referentni centar Ministarstva zdravstva za epilepsiju i konvulzivne bolesti razvojne dobi, Z. Z. D. N. I. D. P., Nišević, J. R., Prpić, I., Referentni centar Ministarstva zdravstva za epilepsiju i konvulzivne bolesti razvojne dobi, Z. Z. D. N. I. D. P., Kolić, I., & Referentni centar Ministarstva zdravstva za epilepsiju i konvulzivne bolesti razvojne dobi, Z. Z. D. N. I. D. P. (2016) · Medicina · doi:10.21860/medflum2016_4ramr · Cited by 2
Broadening the scope of multigene panel analysis for adult epilepsy patients
Lee, S., Kang, M., So, K. H., Jang, R., Shin, Y. W., Jang, S., Yoon, J. G., Kim, S., Kim, M., Chu, K., et al. (2024) · Epilepsia Open · doi:10.1002/epi4.12993 · Cited by 2
Delphi consensus on referral criteria for pediatric patients with suspected Dravet syndrome
Aledo‐Serrano, Á., Boronat, S., García-Peñas, J. J., Ron, A. G., Gil‐Nagel, A., Uranga, J. J. R., Sánchez-Carpintero, R., Smeyers, P., & Villanueva, V. (2025) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2025.110401 · Cited by 2
Sisodiya, S. M., Balestrini, S., Berkovic, S. F., Bhatia, K. P., Clayton, L. M. S., Cross, J. H., Eldred, C., Gambardella, A., Guerrini, R., Nabbout, R., et al. (2025) · Epilepsia · doi:10.1111/epi.18582 · Cited by 2
“3 But the issues outlined above raise serious concerns that the observations made by the authors may not be due to neurodegeneration in DS and may at least partly arise due to other factors.”
Self-citationBerio, A., Mangiante, G., & Piazzi, A. (2014) · La Pediatria Medica e Chirurgica · doi:10.4081/pmc.2014.100 · Cited by 2
Management of Epilepsy in Neonates and Infants
Yozawitz, E., & Moshé, S. (2015) · Wiley eBooks · doi:10.1002/9781118936979.ch13 · Cited by 1
Dam, V. V., & Korff, C. M. (2013) · Schweizer Archiv für Neurologie und Psychiatrie · doi:10.4414/sanp.2013.00174 · Cited by 3
Class Association Rules based Feature Selection for Diagnosis of Dravet Syndrome
Dwarakanath, B., & Kumar, K. R. (2014) · Cited by 2
Focal epilepsy due to de novo SCN1A mutation
Laur, D., Dozières‐Puyravel, B., Iléa, A., Nava, C., Delanöe, C., Nasser, H., Leguern, É., & Auvin, S. (2021) · Epileptic Disorders · doi:10.1684/epd.2021.1285 · Cited by 2
SCN1A and Its Related Epileptic Phenotypes
Sullo, F., Pasquetti, E., Patanè, F., Bianco, M. L., Marino, S. D., Polizzi, A., Falsaperla, R., Ruggieri, M., Zanghì, A., & Praticò, A. D. (2021) · Journal of Pediatric Neurology · doi:10.1055/s-0041-1727260 · Cited by 2
Motor and behavioral phenotype of Dravet syndrome in adulthood
Martin, P., & Kümmerle, A. (2022) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2022.108601 · Cited by 2
Somatic co‐morbidities in epilepsy
Nový, J. (2015) · UCL Discovery (University College London) · Cited by 2
Alvarado-Ramos, N., Rosario-Rivera, J. M., Rivera-Pedraza, E., Melero-Guzmán, A., Centeno, A., Beltrán, S. J., & Vega, A. P. (2026) · BMC Pediatrics · doi:10.1186/s12887-026-06658-0 · Cited by 1
“Haploinsufficiency of these genes has been strongly associated with epilepsy phenotypes, including Dravet syndrome and other early-onset epileptic enceph-alopathies [10].”
Kwetsie, H., van Ool, J. S., Snoeijen‐Schouwenaars, F. M., Rampen, A. J. J., van Karnebeek, C., Festen, D. A. M., & van Eeghen, A. M. (2026) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2026.110985 · Cited by 1
Kerr, W. T., & McFarlane, K. N. (2026) · Epilepsia · doi:10.1002/epi.70247 · Cited by 1
“18 In addition to treating the seizures caused by epilepsy, comprehensive epilepsy center evaluation can both identify and address co-occurring and syndromic features of epilepsy.”
Giorgis, V. D., Bernardina, B. D., Brambilla, I., Helmstaedter, C., Kotulska, K., Lagae, L. G., Malenica, M., Aaberg, K. M., Lossius, M. I., Myren, S., et al. (2026) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2026.111112 · Cited by 1
ISDN2014_0117: Brain morphometry of Dravet Syndrome
Pérez, A., García‐Pentón, L., Canales-Rodríguez, E. J., Lerma‐Usabiaga, G., Davidson, D. J., Alemán‐Gómez, Y., Iturria‐Medina, Y., Acha, J., & Carreiras, M. (2015) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2015.04.096 · Cited by 1
Richards, K., & Petrou, S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804066-9.00053-5 · Cited by 1
Three-Dimensional Stereophotogrammetric Analysis of Adults Affected by Dravet Syndrome
Pucciarelli, V., PIAZZA, E., Ragona, F., Gibelli, D. M., Granata, T., Dolci, C., & Sforza, C. (2017) · International Conference on 3D Body Scanning Technologies (3DBST) · doi:10.15221/17.163 · Cited by 1
“Some patients present different degree of gait impairment, determined by the combination of extrapiramidal signs and orthopedic anomalies (kyphosis, scoliosis, flat feet and valgus knees) [10-12].”
BackgroundManaging Status Epilepticus in a Child with Dravet Syndrome: How Difficult It Could Be?
Badv, R. S., Ghamari, A., Ashrafi, M. R., Mohammadi, M., Malamiri, R. A., & Heidari, M. (2021) · Journal of Pediatric Epilepsy · doi:10.1055/s-0041-1723951 · Cited by 1
Causal correlation between seizure activity and brain damage
Librizzi, L., Verde, D. V., & de Curtis, M. (2025) · Neurological Sciences · doi:10.1007/s10072-025-08209-4 · Cited by 1
“Interestingly, the postmortem neuropathological analysis of patients brains with progressive and severe epileptic encephalopathies may have a normal appearance [16].”
Evidence demands action: An invitation to share the burden of proof
Andrade, D. M., Berg, A. T., Selvarajah, A., Sabo, A., Gorodetsky, C., Marques, P., Chandran, I., Thompson, M. D., Ali, Q. Z., McAndrews, M. P., et al. (2025) · Epilepsia · doi:10.1111/epi.18583 · Cited by 1
“17 Not all neurodegenerative diseases can be reduced to tauopathies and synucle-inopathies.”
Genetic studies of the common epilepsies: genome-wide association studies in the partial epilepsies
Catarino, C. B. (2014) · UCL Discovery (University College London) · Cited by 1
Self-citation
Metadata
- Authors
- Catarino, C. B., Liu, J. Y. W., Liagkouras, I., Gibbons, V. S., Labrum, R. W., Ellis, R., Woodward, C., Davis, M. B., Smith, S. J., Cross, J. H., Appleton, R. E., Yendle, S. C., McMahon, J. M., Bellows, S. T., Jacques, T. S., Zuberi, S. M., Koepp, M. J., Martinian, L., Scheffer, I. E., Thom, M., & Sisodiya, S. M.
- Affiliations
- National Hospital for Neurology and Neurosurgery (GB)
- Royal Hospital for Children (GB)
- Great Ormond Street Hospital (GB)
- Alder Hey Children's NHS Foundation Trust (GB)
- The University of Melbourne (AU)
- Royal Children's Hospital (AU)
- Corresponding author
- Sisodiya, S. M.
- ORCID
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-06-29
- Volume
- 134
- Issue
- 10
- Pages
- 2982-3010
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- PMC
- PMC3187538
- OpenAlex
- W2147751393
- Cited by
- 227
- References
- 88
- Citations by year
- 2026: 13 · 2025: 17 · 2024: 13 · 2023: 11 · 2022: 15 · 2021: 21 · 2020: 16 · 2019: 13 · 2018: 12 · 2017: 13 · 2016: 17 · 2015: 12 · 2014: 19 · 2013: 19 · 2012: 14
- FWCI
- 11.89
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- cc-by-nc
- Locations
- Brain (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by-nc)
- WestminsterResearch (University of Westminster) (submittedVersion, cc-by-nc)
- Funders
- Wellcome Trust (084730)
- National Institute for Health and Care Research
- Great Ormond Street Hospital Charity
- University College London Hospitals NHS Foundation Trust
- Medical Research Council
- National Health and Medical Research Council
- Topics
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmacological Effects and Toxicity Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
- Keywords
- Dravet syndrome, epileptic encephalopathy, SCN1A mutations, adult-onset epilepsy, long-term clinical course, neuropathology, dysphagia, cognitive decline, drug-resistant epilepsy, seizure semiology, postmortem brain
- MeSH terms
- Adult, Aged, Brain, Cognition Disorders, Epilepsies, Myoclonic, Female, Humans, Male, Middle Aged, Mutation, Nerve Tissue Proteins, Syndrome, Sodium Channels, Disease Progression, NAV1.1 Voltage-Gated Sodium Channel
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.